1. Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300. (24th July 2018) Authors: Bang, Y -J; Ruiz, E Yañez; Van Cutsem, E; Lee, K -W; Wyrwicz, L; Schenker, M; Alsina, M; Ryu, M -H; Chung, H -C; Evesque, L; Al-Batran, S -E; Park, S H; Lichinitser, M; Boku, N; Moehler, M H; Hong, J; Xiong, H; Hallwachs, R; Conti, I; Taieb, J Journal: Annals of oncology Issue: Volume 29:Number 10(2018) Page Start: 2052 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluation of prognostic risk models for postoperative pulmonary complications in adult patients undergoing major abdominal surgery: a systematic review and international external validation cohort study. Issue 7 (July 2022) Authors: Kouli, O; Murray, V; Bhatia, S; Cambridge, WA; Kawka, M; Shafi, S; Knight, SR; Kamarajah, SK; McLean, KA; Glasbey, JC; Khaw, RA; Ahmed, W; Akhbari, M; Baker, D; Borakati, A; Mills, E; Thavayogan, R; Yasin, I; Raubenheimer, K; Ridley, W Journal: Lancet Issue: Volume 4:Issue 7(2022) Page Start: e520 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗